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Following publication of the aforementioned
article, the authors noted a minor error in
Table 1 and two small errors in Table 2. In
Table 1, the Eron Class III Clinical Criteria
should read CrCl \30 mL/min or on dialysis,
not CrCl\20 mL/min. In Table 2, Distribution
of SOLO patients in modified Eron Classes I–III,
the number of outpatients receiving
vancomycin (VAN) in Class I should be 111,
not 11. The total number of inpatients (Class
I–III) was omitted, n = 1143 (59.8%).
The online version of the original article can be found
under doi:10.1007/s40121-016-0119-9.
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Table 2 Distribution of SOLO patients in modiﬁed Eron Classes I–III (mITT population, n = 1959)
Class I Class II Class III Total (Class I–III)
SOLO mITT (n = 1959) 520 (26.5%) 790 (40.3%) 600 (30.6%) 1910
Inpatients, n (%) 301 (57.9%) 431 (54.6%) 411 (68.5%) 1143 (59.8%)
ORI, n 144 224 203 571
VAN, n 157 207 208 572
Outpatients, n (%) 219 (42.1%) 359 (45.4%) 189 (31.5%) 767 (40.2%)
ORI, n 108 182 89 379
VAN, n 111 177 100 388
mITT modiﬁed intent-to-treat, ORI oritavancin, VAN vancomycin
Table 1 Clinical criteria used to deﬁne modiﬁed Eron Classes I–IV
Eron class Clinical criteria
IV Bacteremia (positive blood culture); or
Absolute total neutrophils count\500
III Meeting SIRS criteria
CrCl\30 mL/min or on dialysis
ALT/AST[10-times ULN
Heart rate[90/min, breath rate[20/min, or systolic BP\90 mmHg; or
Cancer
II Age C75 years old
Glucose[11.1 mmol/L
Congestive heart failure at the randomization
30 mL/min\CrCl\60 mL/min
Hepatitis (excluding AST/ALT[10-times ULN)
Peripheral vascular disease
Diabetes mellitus
Fever (temperature[38.0 C); or
BMI C30 kg/m2
I For the patients who didn’t meet Classes II–IV
ALT alanine transaminase, AST aspartate transaminase, BMI body mass index, BP blood pressure, CrCl creatinine clearance,
SIRS systemic inﬂammatory response syndrome, ULN upper limit of normal
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